Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NEO NYSEARCA:TTT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNEONeoGenomics$6.31+1.1%$6.67$4.72▼$19.11$815.13M1.541.95 million shs1.06 million shsTTTProShares UltraPro Short 20+ Year Treasury$75.64-1.8%$75.96$54.12▼$87.71$24.96M-0.137,719 shs1,357 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNEONeoGenomics+0.48%+7.22%0.00%-21.90%-61.43%TTTProShares UltraPro Short 20+ Year Treasury+0.98%+4.43%-3.71%-4.44%+25.71%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNEONeoGenomics3.913 of 5 stars4.23.00.00.02.53.31.3TTTProShares UltraPro Short 20+ Year TreasuryN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNEONeoGenomics 2.33Hold$12.75102.06% UpsideTTTProShares UltraPro Short 20+ Year Treasury 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CXL, NEO, SCPA, and TTT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/4/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$12.00 ➝ $11.007/30/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.007/30/2025NEONeoGenomicsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral7/29/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.50 ➝ $8.007/29/2025NEONeoGenomicsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform(Data available from 8/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNEONeoGenomics$660.57M1.23$0.45 per share14.15$7.03 per share0.90TTTProShares UltraPro Short 20+ Year TreasuryN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNEONeoGenomics-$78.73M-$0.81N/A70.11N/A-15.10%-2.72%-1.54%11/4/2025 (Estimated)TTTProShares UltraPro Short 20+ Year TreasuryN/AN/A5.18∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNEONeoGenomicsN/AN/AN/AN/AN/ATTTProShares UltraPro Short 20+ Year Treasury$1.311.73%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNEONeoGenomics0.403.923.58TTTProShares UltraPro Short 20+ Year TreasuryN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNEONeoGenomics98.50%TTTProShares UltraPro Short 20+ Year Treasury20.88%Insider OwnershipCompanyInsider OwnershipNEONeoGenomics2.40%TTTProShares UltraPro Short 20+ Year Treasury1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNEONeoGenomics2,200129.18 million126.08 millionOptionableTTTProShares UltraPro Short 20+ Year TreasuryN/A330,000N/ANot OptionableCXL, NEO, SCPA, and TTT HeadlinesRecent News About These CompaniesCSE Bulletin: Delist - TruTrace Technologies Inc. (TTT)July 24, 2025 | newsfilecorp.comNProShares UltraPro Short 20+ Year Treasury (TTT) Dividend History & Ex ...July 11, 2025 | fxempire.comFProShares UltraPro Short 20+ Year Treasury (TTT) - Investing.comJune 30, 2025 | investing.comTop Performing Leveraged/Inverse ETFs: 04/13/2025April 17, 2025 | etftrends.comEUltraPro Short 20+ Year Treasury declares quarterly distribution of $0.4934March 28, 2025 | msn.com(TTT) Investment AnalysisFebruary 9, 2025 | news.stocktradersdaily.comNProShares UltraShort 20+ Year Treasury ETFJanuary 17, 2025 | seekingalpha.comInverse Treasury ETFs Rallying on Spike in YieldsJanuary 8, 2025 | zacks.comProShares UltraPro Short 20+ Year Treasury ETF declares $3.3077 dividendDecember 23, 2024 | seekingalpha.comTravel Through Trauma Redefines Healing Through ExplorationNovember 19, 2024 | businesswire.comUBT ProShares Ultra 20+ Year Treasury ETFOctober 17, 2024 | seekingalpha.comProShares UltraPro Short 20+ Year TreasuryOctober 15, 2024 | wsj.comHow To Trade (TTT)September 22, 2024 | news.stocktradersdaily.comNProShares UltraShort 20+ Year TreasuryAugust 18, 2024 | markets.businessinsider.com(TTT) Investment Analysis and AdviceAugust 18, 2024 | news.stocktradersdaily.comN(TTT) Pivots Trading Plans and Risk ControlsAugust 4, 2024 | news.stocktradersdaily.comNLearn to Evaluate (TTT) using the ChartsJuly 25, 2024 | news.stocktradersdaily.comNTop Performing Leveraged/Inverse ETFs: 06/30/2024July 2, 2024 | etftrends.comECapitalize on Yield Surge With Inverse Treasury ETFApril 3, 2024 | zacks.comProShares UltraPro Short 20+ Year Treasury (TTT)February 13, 2024 | uk.investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCXL, NEO, SCPA, and TTT Company DescriptionsNeoGenomics NASDAQ:NEO$6.31 +0.07 (+1.12%) Closing price 04:00 PM EasternExtended Trading$6.22 -0.09 (-1.35%) As of 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.ProShares UltraPro Short 20+ Year Treasury NYSEARCA:TTT$75.64 -1.40 (-1.82%) As of 04:10 PM EasternThe ProShares UltraPro Short 20+ Year Treasury (TTT) is an exchange-traded fund that is based on the U.S. Treasury 20+ Year index. The fund provides 3x inverse exposure, reset daily, to a market-value-weighted index that tracks the performance of US Treasury securities with remaining maturities greater than 20 years. TTT was launched on Mar 27, 2012 and is managed by ProShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Home Depot Holds Gains After Narrow Q2 Misses Medtronic: The Opportunity Gets Healthier for Income Investors Palo Alto Networks Uptrend Confirmed! New Highs Set by Year’s End Micron Stock Still Cheap Despite 25% Rally, Analysts Say Qualcomm Just Passed 1 Major Test, But Can It Pass the Next? D-Wave Buying Spree: Will These Firms Be Potential Targets? Lyft's Billion-Dollar Signal: Why Wall Street Is Betting Big Can AI Defense Contracts Push Palantir Shares Higher? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access